Advances knee brace line with innovative, certified medical device providing top-rated impact protection at an affordable price
CAPE TOWN, South Africa (January 16, 2019) Leatt Corporation, (OTCQB: LEAT), a leading developer and marketer of protective equipment and ancillary products for a wide variety of sports, especially extreme high-velocity sports, today announced the official launch of its new Z-Frame knee brace.
Engineered to help reduce knee forces, the Z-Frame limits knee injuries and is CE certified as both a medical and impact protection device.
The Z-frame is made of an injected composite chassis with slim hinges for a superior bike feel. The new knee brace is available in sizes S-XL and retails for $299.99/€299.00/£269.99 for a pair.
“Leatt continues to expand its product lines where science and performance mesh and provide industry leading innovation designed to improve safety and performance for athletes in extreme sports,” commented Leatt Chief Executive Officer, Sean Macdonald. “Our Z-Frame knee brace is CE certified as both a medical device and for impact protection. It is carefully designed to provide industry leading protection, deflecting or absorbing impact depending on the situation. Market reception for this knee brace has been positive to date and we expect that it will contribute to our continued growth in 2019.”
Dr. Christopher Leatt, Chairman of the Board and lead Research and Development consultant added, “Leatt continues to lead the industry in research and development and advanced product testing, as we continue our legacy of developing the highest quality, safety and protective gear for athletes around the world. I am proud of our new Z-Frame knee brace and believe that it will raise the bar for protective gear for the industry.”
Leatt® develops personal protective equipment and ancillary products for all forms of sports, especially action sports. The Leatt-Brace® is an award-winning neck brace system considered the gold standard for neck protection for anyone wearing a crash helmet as a form of protection. It was designed for participants in action sports or riding motorcycles, bicycles, all-terrain vehicles, snowmobiles and other vehicles.
This press release may contain forward-looking statements regarding Leatt Corporation (the “Company”) within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the impact of the new Z-Frame knee brace on the Company’s results of operation and general financial outlook; the likelihood that the Company will continue to develop the highest quality, safety and protective gear for athletes around the world, s or that the Company will derive financial benefit from the sale of such products; the general ability of the Company to achieve its commercial objectives; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “seeks,” “should,” “could,” “intends,” or “projects” or similar expressions, and involve known and unknown risks and uncertainties. These statements are based upon the Company’s current expectations and speak only as of the date hereof. Any indication of the merits of a claim does not necessarily mean the claim will prevail at trial or otherwise. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company’s actual results in any endeavor may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties may be beyond our ability to foresee or control. Other risk factors include the status of the Company’s common stock as a “penny stock” and those listed in other reports posted on The OTC Markets Group, Inc.
Tel (646) 536-7331